<DOC>
	<DOCNO>NCT01439672</DOCNO>
	<brief_summary>This protocol investigate physiological parameter include insulin sensitivity counterregulatory function use mixed meal test induce hypoglycemia subject type I diabetes .</brief_summary>
	<brief_title>Insulin Sensitivity , Impaired Counterregulation , Glucose Variability</brief_title>
	<detailed_description>The principal idea propose research : order successful , closed-loop control glucose diabetes must adapt individual physiologic characteristic behavioral profile person . We propose build system use observer patient ' behavior metabolic state control modules responsible insulin delivery hypoglycemia prevention . In phase project , investigate relationship insulin sensitivity impaired counterregulation blood glucose variability , aim develop algorithmic physiology observer , track specific parameter glucose variability recurrent hypoglycemia marker change person 's insulin sensitivity counterregulatory ability .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type I diabetes mellitus ( TIDM ) ( defined American Diabetes Association criterion judgment physician ) least two year prior enrollment study . Use insulin pump treat diabetes least six month prior study . Ability use bolus calculator function current insulin pump predefined parameter glucose goal , carbohydrate ratio , insulin sensitivity factor . Age 21 64 year . Adults age 65 likely medical exclusion followup Phase 2 study , involve induced hypoglycemia . Completed Phase 1 Institutional Review Board ( IRB ) # 14956 `` Development Behavioral Observer Type 1 Diabetes Mellitus '' Willingness use lispro ( Humalog ) insulin two day prior inpatient admission . Willingness perform SelfMonitoring Blood Glucose ( SMBG ) 4 time per day time meal bedtime . Demonstration proper mental status cognition completion study . Pregnancy Psychiatric disorder would interfere study task ( e.g . mental retardation , substance abuse ) History systemic deep tissue infection methicillinresistant staph aureus Candida albicans Known bleed diathesis dyscrasia Active enrollment another clinical trial Medical condition would make operating insulin pump difficult ( e.g . blindness , severe arthritis , extensive scar tissue sit device insert ) . Anemia ( hematocrit &lt; 36 % [ female ] , &lt; 38 % [ male ] ) , Allergy adverse reaction lispro ( Humalog ) insulin Conditions may increase risk induced hypoglycemia symptomatic heart disease , congestive heart failure , history cerebrovascular event , atrial fibrillation , renal insufficiency ( creatinine &gt; 1.5 ) uncontrolled hypertension ( rest blood pressure &gt; 140/90 ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Type 1 Diabetes Mellitus</keyword>
</DOC>